Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism

I Elia, MC Haigis - Nature metabolism, 2021 - nature.com
Metabolic transformation is a hallmark of cancer and a critical target for cancer therapy.
Cancer metabolism and behaviour are regulated by cell-intrinsic factors as well as …

Interferon-gamma at the crossroads of tumor immune surveillance or evasion

F Castro, AP Cardoso, RM Gonçalves, K Serre… - Frontiers in …, 2018 - frontiersin.org
Interferon-gamma (IFN-γ) is a pleiotropic molecule with associated antiproliferative, pro-
apoptotic and antitumor mechanisms. This effector cytokine, often considered as a major …

Obstacles posed by the tumor microenvironment to T cell activity: a case for synergistic therapies

KG Anderson, IM Stromnes, PD Greenberg - Cancer cell, 2017 - cell.com
T cell dysfunction in solid tumors results from multiple mechanisms. Altered signaling
pathways in tumor cells help produce a suppressive tumor microenvironment enriched for …

The spatial landscape of progression and immunoediting in primary melanoma at single-cell resolution

AJ Nirmal, Z Maliga, T Vallius, B Quattrochi, AA Chen… - Cancer Discovery, 2022 - AACR
Cutaneous melanoma is a highly immunogenic malignancy that is surgically curable at early
stages but life-threatening when metastatic. Here we integrate high-plex imaging, 3D high …

The dark side of IFN-γ: its role in promoting cancer immunoevasion

M Mojic, K Takeda, Y Hayakawa - International journal of molecular …, 2017 - mdpi.com
Interferon-γ (IFN-γ) is a pleiotropic cytokine that has long been praised as an important
effector molecule of anti-tumor immunity, capable of suppressing tumor growth through …

Advancing to the era of cancer immunotherapy

Y Wang, M Wang, HX Wu, RH Xu - Cancer Communications, 2021 - Wiley Online Library
Cancer greatly affects the quality of life of humans worldwide and the number of patients
suffering from it is continuously increasing. Over the last century, numerous treatments have …

The therapeutic potential of targeting tryptophan catabolism in cancer

CA Opitz, LF Somarribas Patterson… - British journal of …, 2020 - nature.com
Based on its effects on both tumour cell intrinsic malignant properties as well as anti-tumour
immune responses, tryptophan catabolism has emerged as an important metabolic regulator …

Immune control by amino acid catabolism during tumorigenesis and therapy

H Lemos, L Huang, GC Prendergast… - Nature Reviews Cancer, 2019 - nature.com
Immune checkpoints arise from physiological changes during tumorigenesis that
reprogramme inflammatory, immunological and metabolic processes in malignant lesions …

Indoleamine 2, 3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4

RB Holmgaard, D Zamarin, DH Munn… - Journal of Experimental …, 2013 - rupress.org
The cytotoxic T lymphocyte antigen-4 (CTLA-4)–blocking antibody ipilimumab results in
durable responses in metastatic melanoma, though therapeutic benefit has been limited to a …

[HTML][HTML] The rationale of indoleamine 2, 3-dioxygenase inhibition for cancer therapy

L Brochez, I Chevolet, V Kruse - European journal of cancer, 2017 - Elsevier
Abstract Indoleamine 2, 3-dioxygenase (IDO, also referred to as IDO1) has been
demonstrated to be a normal endogenous mechanism of acquired peripheral immune …